about
Progress in molecular-based management of differentiated thyroid cancermiRNA expression and function in thyroid carcinomas: a comparative and critical analysis and a model for other cancersA preoperative nomogram for the prediction of ipsilateral central compartment lymph node metastases in papillary thyroid cancer.Analysis options for high-throughput sequencing in miRNA expression profilingMicroRNA-338-3p inhibits thyroid cancer progression through targeting AKT3.Variants in the ATM-CHEK2-BRCA1 axis determine genetic predisposition and clinical presentation of papillary thyroid carcinoma.Autophagy: A potential target for thyroid cancer therapy (Review)Deregulation of miR-146a expression in a mouse model of pancreatic cancer affecting EGFR signaling.Lack of association of miR-146a rs2910164 polymorphism with gastrointestinal cancers: evidence from 10206 subjectsMicroRNAs: promising chemoresistance biomarkers in gastric cancer with diagnostic and therapeutic potential.Association between the rs2910164 polymorphism in pre-Mir-146a sequence and thyroid carcinogenesis.microRNA-339-5p modulates Na+/I- symporter-mediated radioiodide uptake.The role of microRNAs in the biology of rare diseases.Association of Pre-miR-146a rs2910164 Polymorphism with Papillary Thyroid CancerThe polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type.Serum microRNA profiling to distinguish papillary thyroid cancer from benign thyroid masses.MicroRNA as a diagnostic tool in fine-needle aspiration biopsy of thyroid nodules.microRNA-106b-mediated down-regulation of C1orf24 expression induces apoptosis and suppresses invasion of thyroid cancerGender-Specific Variation in the Prognosis of Papillary Thyroid Cancer TNM Stages II to IV.Differential expression profiling and functional analysis of microRNAs through stage I-III papillary thyroid carcinomamicroRNA-141 inhibits thyroid cancer cell growth and metastasis by targeting insulin receptor substrate 2.MicroRNA-375/SEC23A as biomarkers of the in vitro efficacy of vandetanib.Are pre-miR-146a and PTTG1 associated with papillary thyroid cancer?Cumulative risk impact of five genetic variants associated with papillary thyroid carcinoma.MicroRNA-363-3p inhibits papillary thyroid carcinoma progression by targeting PIK3CA.MicroRNA-related sequence variations in human cancers.Circulating microRNA124-3p, microRNA9-3p and microRNA196b-5p may be potential signatures for differential diagnosis of thyroid nodulesThe emerging role of MIR-146A in the control of hematopoiesis, immune function and cancerDiagnosis of thyroid cancer: state of art.Role of miRNA in head and neck squamous cell carcinoma.MicroRNAs as a potential tool in the differential diagnosis of thyroid cancer: a systematic review and meta-analysis.MicroRNA-196a2 Biomarker and Targetome Network Analysis in Solid Tumors.miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma.Circulating thyroid cancer biomarkers: Current limitations and future prospects.Functional analysis of a novel, thyroglobulin-embedded microRNA gene deregulated in papillary thyroid carcinoma.MicroRNA-21 promotes cell proliferation, migration, and resistance to apoptosis through PTEN/PI3K/AKT signaling pathway in esophageal cancer.Cell penetrating peptide of sodium-iodide symporter effect on the I-131 radiotherapy on thyroid cancer.miR-29a suppresses growth and metastasis in papillary thyroid carcinoma by targeting AKT3.Down-regulation of miR-144 promotes thyroid cancer cell invasion by targeting ZEB1 and ZEB2.Nodular thyroid disease in the elderly: novel molecular approaches for the diagnosis of malignancy.
P2860
Q26999887-6D0E5D7D-343C-423B-9098-14640A670C92Q28078451-205415B4-EB07-4EB6-8B74-ABAD0808819EQ33440071-F71579DF-325D-4DF5-AE89-B605D0D79548Q33557722-DA42F74E-9BAE-49B9-9991-20CF9D66843FQ33733031-1B03E802-579B-4DE4-8156-1DBDB34F8AE9Q33760096-7073A96B-7938-4801-9879-D1BC166836B6Q33933013-DD15731D-5DB6-4E82-990B-8AD9FFCFA923Q33970228-29148A6F-3367-458E-B259-4E4987A67C35Q34326336-04F937FC-9346-49C9-96A9-4E470A4168EFQ34326553-7E27AF17-A523-4F4D-9EBF-389D7890A8BAQ34602449-44537C84-C6F4-4BD9-A10C-52CBB3DDF98BQ34982847-96DC9546-CA17-4EE7-B509-E974B8F3EA88Q35536045-B54DDE8C-358E-4E38-9F18-A37F231C2F6AQ35868081-E420C778-BE0B-4C30-B2AC-FC8CBEBCBC76Q36001440-A5F19C98-021D-44FF-AD0D-DEA41767E33EQ36030561-83B5C34F-A691-4ADD-8725-D9A24E2D8CDCQ36182811-B95A442A-45C9-4D7D-9E8C-C6C8C92B534AQ36414057-5742458D-38DD-4713-A299-8440C6101170Q36469065-05B463B3-80EE-4BB8-82E3-C8B7BF98EF87Q36713429-6456454C-EDCE-4D26-8E4D-C3DF3B8AD62AQ36878582-8B2FE71E-EE93-40FB-8F6A-E03B600AB47FQ37327513-AC1298E9-B328-4A0A-8423-C73FD61E3DCDQ37358228-661B6C6C-9B49-4A1B-B417-66FFD18097E7Q37403877-251781FB-3248-4D7C-A31D-74964C953560Q37596839-12C290EA-B7AE-45AA-9B50-478B8B79A20EQ37636207-22FB30B2-1E67-480D-B8FE-F3C210E1F26DQ37708930-4CB60618-49CE-4A01-9E73-75EC671C58C9Q37997552-52F5C66B-C0F4-4FB9-A530-9686AC6C7EC4Q38108825-65E15F77-3548-4595-8E52-C7D2F940130FQ38264776-1347E618-2811-4576-BF92-5F8888910C37Q38288967-96844310-338F-427C-A07C-A2C1603435AAQ38379591-39532B11-412C-476D-958A-CDF9CF4A3D69Q38395979-FC8C1EBF-52B8-4C03-BF99-C23959D1B08CQ38685267-416C88F9-6CC9-46FF-A834-A64B8B244951Q38693764-CC6823DD-F3B4-455E-92CA-A90E74F1A087Q38737099-A627A640-E710-4A66-B935-601C50001083Q38815793-05E72FC8-C702-4F58-AD32-E8F0500923A2Q38826614-6E1052A1-40AD-408C-9375-8E4042F4CB09Q38980944-021C8CB1-1598-4F55-A208-B8849245800EQ39004661-7284FDED-886A-4EE1-AA08-9595934E92B8
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
MicroRNAs in thyroid cancer.
@ast
MicroRNAs in thyroid cancer.
@en
type
label
MicroRNAs in thyroid cancer.
@ast
MicroRNAs in thyroid cancer.
@en
prefLabel
MicroRNAs in thyroid cancer.
@ast
MicroRNAs in thyroid cancer.
@en
P2860
P356
P1476
MicroRNAs in thyroid cancer.
@en
P2860
P304
P356
10.1210/JC.2011-1004
P407
P577
2011-08-24T00:00:00Z